Skip to main content
Jerald C Sadoff

Jerald C Sadoff


Senior Advisor Vaccine Development, JRD Vaccine Therapeutic Area for Janssen R&D US, Johnson & Johnson
United States


Jerald C Sadoff is Senior Advisor Vaccine Development, JRD Vaccine Therapeutic Area for Janssen R&D US. He has spent his entire career developing vaccines against a large number of bacterial, viral and parasitic diseases, 13 of which have been approved for human use and with several others currently in Phase 2B and Phase 3 clinical studies.

He is currently the Medical Lead for Phase 1, 2 and pivotal efficacy studies of the Janssen SARS-COV-2 vaccine. He serves on several Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD) Scientific Advisory Boards for National Institute of Health-sponsored HIV vaccine efforts and is a member of the NIAID AIDS Vaccine Research Working Group. Over the past 35 years, he has authored and co-authored over 350 articles, book chapters and abstracts and registered 18 patents.

The IAS promotes the use of non-stigmatizing, people-first language. The translations are all automated in the interest of making our content as widely accessible as possible. Regretfully, they may not always adhere to the people-first language of the original version.